Advertisement

Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging

Published:April 22, 2021DOI:https://doi.org/10.1016/j.euf.2021.03.027
      To read this article in full you will need to make a payment

      References

      1. Cancer Research UK. Prostate cancer statistics. www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer#heading-One.

        • Thompson I.M.
        • Pauler D.K.
        • Goodman P.J.
        • et al.
        Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter.
        N Engl J Med. 2004; 350: 2239-2246
        • Lilja H.
        • Ulmert D.
        • Vickers A.J.
        Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
        Nat Rev Cancer. 2008; 8: 268-278
        • Martin R.M.
        • Donovan J.L.
        • Turner E.L.
        • et al.
        Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial.
        JAMA. 2018; 319: 883-895
        • Pinsky P.F.
        • Prorok P.C.
        • Yu K.
        • et al.
        Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.
        Cancer. 2017; 123: 592-599
        • Hugosson J.
        • Roobol M.J.
        • Månsson M.
        • et al.
        A 16-yr follow-up of the European Randomized study of Screening for Prostate Cancer.
        Eur Urol. 2019; 76: 43-51
        • Hugosson J.
        • Godtman R.A.
        • Carlsson S.V.
        • et al.
        Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality.
        Scand J Urol. 2018; 52: 27-37
        • National Institute for Health and Care Excellence
        Prostate cancer: diagnosis and management. NICE guideline NG131.
        NICE, London, UK2019
        www.nice.org.uk/guidance/ng131
        • Ahmed H.U.
        • El-Shater Bosaily A.
        • Brown L.C.
        • et al.
        Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
        Lancet. 2017; 389: 815-822
        • Devine W.
        • Giganti F.
        • Johnston E.W.
        • et al.
        Simplified luminal water imaging for the detection of prostate cancer from multiecho T(2) MR images.
        J Magn Reson Imaging. 2019; 50: 910-917